3rd Annual ACMA/DGE

MedComm 3.0

October 19-20, 2020

Philadelphia, PA

Event Overview

In the digital age the pharmaceutical industry relies on their medical communication teams to interpret a tremendous amount of information into user-friendly stories that resonate with audiences. The second annual MedComm 3.0 EAST conference aims to bring industry professionals an interactive platform to explore advanced solutions to communication challenges that the pharmaceutical industry faces.

  • Discuss the changing environment for publications professionals
  • Break down silos when working with commercial teams
  • Develop frameworks for scientific engagement
  • Discuss the importance of MI omni-channel content strategies
  • Achieve greater transparency and promote practices that protect the integrity of authorship

Learn and network with influential speakers who will share practices they've implemented to preserve company reputation and advocate for patients in a highly-regulated environment.

Hyatt Regency Orange County

Image

11999 Harbor Blvd.
Garden Grove, CA 92840
(714) 750-1234

Hotel Website

Special Event Rate
Coming Soon

Top 5 Reasons to Attend

  1. Rare opportunity to learn and prosper from women who’ve achieved C-Level positions
  2. Hear ideas and best practices for overcoming barriers to success
  3. Network with peers, mentors and those on their “way up” in leadership roles
  4. Create a road map for achieving your next leadership role in Pharma or Healthcare
  5. Learn strategies for fostering diversity and inclusion

Attendee Profile

Mid-Level Leaders who are emerging and seeking knowledge to facilitate upward mobility. This conference is for Managers, Directors and VPs looking to continue their career path to Senior Level, Executive Level and C-Suite Roles with:

  • Pharmaceutical companies
  • Hospitals, healthcare system & healthcare providers
  • Health insurance companies
  • Biotech companies
  • Medical device manufacturers
  • Healthcare related associations, foundations, solutions providers, educational organizations, government entities and venture capitalists

Tuesday, December 3rd, 2019 | Day 2


8:00 AM - 9:00 AM

Continental Breakfast

9:00 AM - 9:15 AM

Recap of Day One Sessions

9:15 AM - 10:45 AM

Meetings with the FDA

To assist in navigating the intricate web of regulations and requirements, the FDA offer several key points of interaction during the development process.

  • Learn what meetings are possible for your products during your development life cycle and what you should aim to get out of them.
  • Learn how to take advantage of these meetings from scheduling to planning and conducting the meeting to gain full understanding and actionable output.
  • Review case studies of successful negotiation and communication during meetings.
  • See lessons learned from less successful meetings and how to manage that during the meeting and recover after the meeting.

10:45 AM - 11:15 AM

Networking Break

11:15 AM - 1:15 PM

Beginning with the End Target in Mind

The largest goal of every development program is to help patients and enhance their lives. However, that cannot be accomplished philanthropically, so you have to consider what you need to have at the end of the day in order to make money. So how do you ensure that you will hit the target!

  • What is a Target Product Profile (TPP) and how do you create it.
  • One step beyond the TPP – the claims needed to resonate with customers.
  • Materializing the development plan from your targets.
  • Practical Application Exercise: Turn a TPP into a Development Program.

TWO DAYS OF EDUCATION AND OPPORTUNITY

DON'T MISS IT

REGISTER NOW

2019 Speaker Faculty


Dawn Anderson

Dawn Anderson

Managing Director, Life Sciences Strategy and Operations, R&D Practice
Deloitte

Craig Lipset

Craig Lipset

Head of Clinical Innovation
Pfizer Inc.

Kyle Faget

Kyle Faget

Special Counsel
Foley & Lardner, LLP

Jeff Kingsley

Jeff Kingsley

CEO
IACT Health

Ross Friedberg

Ross Friedberg

General Counsel & Chief Privacy Officer
Doctor on Demand

Monica Chmielewski

Monica Chmielewski

Attorney
Foley & Lardner, LLP

Amir Lahav

Amir Lahav

Digital Medicine and Clinical Innovation Lead
Pfizer

Michael Song

Michael Song

Senior Manager, Drug Delivery and Device Development
MedImmune

Jane Fang

Jane Fang

Director, R&D Information Head for Clinical Biologics
AstraZeneca

Hassan Kadhim

Hassan Kadhim

Director, Head of Clinical Trial Business Capabilities
Bristol-Myers Squibb

Kayla Kostelecky

Kayla Kostelecky

PhD Candidate, Health Care Ethics
Saint Louis University

Terri Ellsworth

Terri Ellsworth

Director of Professional Relations, Patient Advocacy
Accreditation Council for Medical Affairs (ACMA)

MarlaJan Wexler

MarlaJan Wexler

Patient Advocacy & Education

Jonathan Cotliar

Jonathan Cotliar

Chief Medical Officer
Science37

Kelly Conway

Kelly Conway

Patient

John Reites

John Reites

Chief Product Officer & Partner
THREAD

Michelle Smith

Michelle Smith

Product Delivery, Advisor, Technical Center of Excellence
Eli Lilly and Company

Holly Merrill

Holly Merrill

Senior Director, Training & Education
Science 37

Jeffrey Zucker

Jeffrey Zucker

SVP Global Clinical Operations, Site Management & Trial Optimization
Worldwide Clinical Trials

Karen Beyers

Karen Beyers

Senior Director, MAF Clinical Operations
Johnson & Johnson

REGISTRATION PRICING


CONFERENCE ATTENDEE

* SUPER EARLY BIRD *

Before 6/5/20

$1,596

EARLY BIRD

Before 8/7/20

$1,796

STANDARD

After 8/7/20

$1,996

ON-SITE

Register at Event

$2,196

CONFERENCE LIVE VIRTUAL STREAM

VIRTUAL LIVE STREAM

Register Anytime

$896

Register 2 Attendees, Get 1 Complimentary Registration*!

Interested in sending groups of 7 or more? Contact us directly for pricing.

* Standard Pricing Only

EVENT SPONSORS

SPONSOR THIS EVENT

Contact Amy Chapman at (561) 571-7687
or achapman@dgeconfs.com


MEDIA PARTNERS

Image

PREMIER MEDIA PARTNER